These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1682644)

  • 1. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone.
    Norman JE; Thong KJ; Baird DT
    Lancet; 1991 Nov; 338(8777):1233-6. PubMed ID: 1682644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.
    el-Refaey H; Templeton A
    Br J Obstet Gynaecol; 1994 Sep; 101(9):792-6. PubMed ID: 7947529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of abortion with mifepristone and misoprostol in early pregnancy.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1992 Dec; 99(12):1004-7. PubMed ID: 1477003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
    Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
    N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol.
    McKinley C; Thong KJ; Baird DT
    Hum Reprod; 1993 Sep; 8(9):1502-5. PubMed ID: 8253942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
    el-Refaey H; Rajasekar D; Abdalla M; Calder L; Templeton A
    N Engl J Med; 1995 Apr; 332(15):983-7. PubMed ID: 7885426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Gottlieb C
    Hum Reprod; 1994 Jun; 9 Suppl 1():121-5. PubMed ID: 7962458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens.
    el-Refaey H; Templeton A
    Hum Reprod; 1995 Feb; 10(2):475-8. PubMed ID: 7769082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route.
    el-Refaey H; Templeton A
    Contraception; 1994 Feb; 49(2):111-4. PubMed ID: 8143450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin.
    Phillips K; Berry C; Mathers AM
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):175-6. PubMed ID: 8730620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on uterine contractility following mifepristone and various routes of misoprostol.
    Gemzell-Danielsson K; Bygdeman M; Aronsson A
    Contraception; 2006 Jul; 74(1):31-5. PubMed ID: 16781257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of early pregnancy through a combination of the antiprogestin and prostaglandin analogue.
    Maria B; Stampf F; Goepp A; Dubois C
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):35-40. PubMed ID: 2376278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of mifepristone (RU 486).
    Baird DT
    Ann Med; 1993 Feb; 25(1):65-9. PubMed ID: 8435192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate and misoprostol for early abortion.
    Creinin MD; Darney PD
    Contraception; 1993 Oct; 48(4):339-48. PubMed ID: 8222661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.